PL374273A1 - Krystaliczna zasadowa wenlafaksyna i nowe polimorfy chlorowodorku wenlafaksyny oraz sposoby ich wytwarzania - Google Patents

Krystaliczna zasadowa wenlafaksyna i nowe polimorfy chlorowodorku wenlafaksyny oraz sposoby ich wytwarzania

Info

Publication number
PL374273A1
PL374273A1 PL02374273A PL37427302A PL374273A1 PL 374273 A1 PL374273 A1 PL 374273A1 PL 02374273 A PL02374273 A PL 02374273A PL 37427302 A PL37427302 A PL 37427302A PL 374273 A1 PL374273 A1 PL 374273A1
Authority
PL
Poland
Prior art keywords
venlafaxine
preparing
processes
crystalline
base
Prior art date
Application number
PL02374273A
Other languages
English (en)
Inventor
Ben-Zion Dolitzky
Judith Aronhime
Gennady A. Nisnevich
Shlomit Wizel
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL374273A1 publication Critical patent/PL374273A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/70—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL02374273A 2001-11-30 2002-11-20 Krystaliczna zasadowa wenlafaksyna i nowe polimorfy chlorowodorku wenlafaksyny oraz sposoby ich wytwarzania PL374273A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/000,428 US20020183553A1 (en) 2000-10-19 2001-11-30 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (1)

Publication Number Publication Date
PL374273A1 true PL374273A1 (pl) 2005-10-03

Family

ID=21691493

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02374273A PL374273A1 (pl) 2001-11-30 2002-11-20 Krystaliczna zasadowa wenlafaksyna i nowe polimorfy chlorowodorku wenlafaksyny oraz sposoby ich wytwarzania

Country Status (16)

Country Link
US (4) US20020183553A1 (pl)
EP (1) EP1474379A4 (pl)
JP (1) JP2005511668A (pl)
KR (1) KR20040068163A (pl)
CN (2) CN1617848A (pl)
AU (1) AU2002365874A1 (pl)
CA (1) CA2468728A1 (pl)
HR (1) HRP20040565A2 (pl)
HU (1) HUP0700037A2 (pl)
IL (1) IL162171A0 (pl)
IS (1) IS7289A (pl)
MX (1) MXPA04005193A (pl)
NO (1) NO20042732L (pl)
PL (1) PL374273A1 (pl)
WO (1) WO2003048082A2 (pl)
ZA (1) ZA200404080B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK5762003A3 (en) * 2000-10-19 2003-11-04 Teva Pharma Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
PL361912A1 (pl) * 2000-10-31 2004-10-04 Ciba Specialty Chemicals Holding Inc. Postacie krystaliczne chlorowodorku wenlafaksyny
CN1630631A (zh) * 2001-12-05 2005-06-22 惠氏公司 新的文拉法星盐酸盐多晶型物及其制备方法
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
US20030190352A1 (en) * 2002-03-28 2003-10-09 Synthon Bv Compositions of venlafaxine base
DE10359154A1 (de) * 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
CA2625832A1 (en) * 2005-10-19 2007-04-26 Vinod Kumar Kansal Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
HUE027865T2 (en) 2005-12-01 2016-11-28 Auspex Pharmaceuticals Inc Substituted phenyl ethylamines with serotonergic and / or norepinephrine activity
WO2008140859A1 (en) * 2007-03-15 2008-11-20 Auspex Pharmaceuticals, Inc. Deuterated venlafaxines and 0-desmetylvenlafaxines with serotoninergic and / or norepinephrinergic activity
CN101279926A (zh) * 2008-05-22 2008-10-08 杭州盛美医药科技开发有限公司 盐酸文拉法辛晶型FormⅠ的制备方法
CN104684555A (zh) 2012-09-18 2015-06-03 奥斯拜客斯制药有限公司 囊泡单胺转运体2的氘化苯并喹啉抑制剂的制剂药代动力学
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
HRP20221106T1 (hr) 2015-03-06 2022-11-25 Auspex Pharmaceuticals, Inc. Postupci liječenja abnormalnih nevoljnih poremećaja pokreta

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
SK5762003A3 (en) * 2000-10-19 2003-11-04 Teva Pharma Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
PL361912A1 (pl) 2000-10-31 2004-10-04 Ciba Specialty Chemicals Holding Inc. Postacie krystaliczne chlorowodorku wenlafaksyny
AU2001235970A1 (en) 2000-12-07 2002-06-18 Dr. Reddy's Research Foundation Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
EP1249447B1 (en) * 2001-04-10 2008-10-22 Alembic Limited Intermediate for the production of 1-[2-dimethylamino-1-(4-methoxyphenyl)-ethyl]-cyclohexanol
CN1630631A (zh) * 2001-12-05 2005-06-22 惠氏公司 新的文拉法星盐酸盐多晶型物及其制备方法
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof

Also Published As

Publication number Publication date
WO2003048082A2 (en) 2003-06-12
CA2468728A1 (en) 2003-06-12
US20080167498A1 (en) 2008-07-10
IS7289A (is) 2004-05-27
NO20042732L (no) 2004-06-29
WO2003048082A3 (en) 2004-08-26
US20050049304A1 (en) 2005-03-03
MXPA04005193A (es) 2005-02-22
EP1474379A4 (en) 2006-06-07
JP2005511668A (ja) 2005-04-28
KR20040068163A (ko) 2004-07-30
CN101219962A (zh) 2008-07-16
HRP20040565A2 (en) 2005-08-31
ZA200404080B (en) 2007-12-27
HUP0700037A2 (en) 2007-05-02
EP1474379A2 (en) 2004-11-10
US6924393B2 (en) 2005-08-02
CN1617848A (zh) 2005-05-18
IL162171A0 (en) 2005-11-20
US20040220278A1 (en) 2004-11-04
US20020183553A1 (en) 2002-12-05
AU2002365874A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
IL162171A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AP2004002989A0 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
IL159994A0 (en) Process for preparing 4-aminodiphenylamine
AU2003253188A8 (en) Novel processes and intermediates for preparing triazolo-pyridines
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
HRP20030900A2 (en) Polymorphs of fexofenadine hydrochloride
EP1406855A4 (en) NOVEL PROCESS FOR THE PREPARATION OF RAC-BICALUTAMIDE AND INTERMEDIATE PRODUCTS THEREOF
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
EP1497272A4 (en) METHOD FOR PRODUCING AMIN STEREO ISOMERS
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
HK1056545A (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
SI2181982T1 (sl) Postopek za pripravo venlafaksin hidroklorida oblike I
AU2002357701A1 (en) Polymorphs of fexofenadine base
AU2002337634A1 (en) Process for the preparation of bupropion hydrochloride
PL376832A1 (pl) Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny
AU2003244886A1 (en) Process for preparing tramadol hydrochloride and/or tramadol momohydrate
HK1065777A (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
PL372137A1 (pl) Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny
AU2002308095A1 (en) Process for preparing sertraline hydrochloride polymorphic form ii
HK1050320A (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
AU2002347399A1 (en) Venlafaxine hydrochloride polymorphs
HU0104872D0 (en) New polymorphic forms of venlafaxine

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)